Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 4/9/2026CDE Releases New Clinical Evaluation Guideline for IND Applications to...
  • 4/9/2026CDE Issues New Clinical Evaluation Guideline for Drug Marketing Applic...
  • 4/9/2026Syneron Emerges as a Macrocycle Powerhouse as Funding and AZ Deal Fuel...
  • 4/9/2026Luye Advances Next-Gen Schizophrenia Candidate LY03020 Into Phase II i...
  • 4/9/2026Over Half of China-Listed Drugmakers Grow 2025 Profit as Innovation an...
  • 4/9/2026Gan & Lee Out-Licenses Bi-Weekly GLP-1 Candidate Bofanglutide to JW Ph...
  • 4/9/2026GSK Wins China Approval for Exdensur in Chronic Rhinosinusitis With Na...
  • 4/9/2026NMPA Clears BioGenesis's Recombinant Human Hyaluronidase
  • 4/9/2026Everest Medicines to Acquire Hasten's Asia-Pacific Platform in $250M ...
  • 4/8/2026NMPA Adopts ICH M14 Guideline, Expanding China's Regulatory Framework ...
  • 4/8/2026NMPA Adopts ICH Q8, Q9 and Q10 Q&A (R5)
  • 4/8/2026Merck and Zhifei Shift to Demand-Based China Vaccine Supply Model as G...
  • 4/7/2026Aidea Wins China IND Clearance for Long-Acting HIV PrEP Candidate ACC0...
  • 4/7/2026Bayer Deepens China Innovation Push as Pharma Division Targets 30% Mar...
  • 4/7/2026Kelun-Biotech and HBM's Atopic Dermatitis Bispecific Revealed as TSLP/...
  • 4/7/2026Chengdu NRT Closes CNY 1B Series E to Accelerate Radiopharma Commercia...
  • 4/7/2026Henlius Wins China IND Approval for HLX319, Advancing SC HER2 Breast C...
  • 4/7/2026Adagene, Incyte Launch Clinical Collaboration to Advance Novel MSS Col...
  • 4/3/2026NMPA Suspends Import, Sale and Use of Cadila's Amlodipine Besylate API...
  • 4/3/2026Hengrui Unveils Promising Phase 1 Data for FIC Dual-Target Psoriasis A...
  • 4/3/2026Recent Executive Moves
  • 4/3/2026Myeloid Cure Biotech Secures Over CNY 150M in Series A to Advance Mac...
  • 4/3/2026XellSmart Secures CNY 500M+ to Accelerate Parkinson's, ALS and SCI iPS...
  • 4/3/2026Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...
  • 4/3/2026BDGene Secures Strategic Financing, Relocates Headquarters to Hangzhou...
  • 4/3/2026Earendil Advances AI-Designed TL1A Antibody Into Mid-Stage UC Trial
  • 4/3/2026Abbisko Advances ABSK061 Into US Clinical Development for Achondroplas...
  • 4/3/2026CDE Revises Drug R&D and Technical Review Communication Management Mea...
  • 4/2/2026NMPA Releases Implementation Opinions on "AI + Drug Regulation"
  • 4/2/2026NMPA Issues Notice on Advancing Segmented Manufacturing of Biologics
  • Page:1/61 Total number of articles:1828: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group